Interferon β in multiple sclerosis: is IL-12 suppression the key?

This publication has 25 references indexed in Scilit:

• Two Roads Diverged: Interferon α/β– and Interleukin 12–mediated Pathways in Promoting T Cell Interferon γ Responses during Viral Infection
  The Journal of Experimental Medicine, 1999
• Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.
  Journal of Clinical Investigation, 1998
• Management of Multiple Sclerosis
  New England Journal of Medicine, 1997
• Human recombinant interferon‐β influences T helper subset differentiation by regulating cytokine secretion pattern and expression of homing receptors
  European Journal of Immunology, 1997
• Selective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 Cells
  The Journal of Experimental Medicine, 1997
• Beta-interferon and multiple sclerosis
  Trends in Neurosciences, 1997
• IL-12 unmasks latent autoimmune disease in resistant mice.
  The Journal of Experimental Medicine, 1996
• Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions.
  The Journal of Experimental Medicine, 1995
• Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor α and tumor necrosis factor β
  Journal of Neuroimmunology, 1995
• Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.
  The Journal of Experimental Medicine, 1995